Prins ND

References (3)

Title : Effects of Oral ALZ-801\/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease - Hey_2024_Drugs__
Author(s) : Hey JA , Abushakra S , Blennow K , Reiman EM , Hort J , Prins ND , Sheardova K , Kesslak P , Shen L , Zhu X , Albayrak A , Paul J , Schaefer JF , Power A , Tolar M
Ref : Drugs , : , 2024
Abstract :
PubMedSearch : Hey_2024_Drugs__
PubMedID: 38902571

Title : Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308
Author(s) : Jiang Y , Alam JJ , Gomperts SN , Maruff P , Lemstra AW , Germann UA , Stavrides PH , Darji S , Malampati S , Peddy J , Bleiwas C , Pawlik M , Pensalfini A , Yang DS , Subbanna S , Basavarajappa BS , Smiley JF , Gardner A , Blackburn K , Chu HM , Prins ND , Teunissen CE , Harrison JE , Scheltens P , Nixon RA
Ref : Nat Commun , 13 :5308 , 2022
Abstract :
PubMedSearch : Jiang_2022_Nat.Commun_13_5308
PubMedID: 36130946

Title : The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial - Prins_2014_Alzheimers.Res.Ther_6_47
Author(s) : Prins ND , van der Flier WA , Knol DL , Fox NC , Brashear HR , Nye JS , Barkhof F , Scheltens P
Ref : Alzheimers Res Ther , 6 :47 , 2014
Abstract :
PubMedSearch : Prins_2014_Alzheimers.Res.Ther_6_47
PubMedID: 25478019